发明名称 |
Dry eye treatments |
摘要 |
Described herein are methods and pharmaceutical formulations for treating dry eye disease. |
申请公布号 |
US9597284(B2) |
申请公布日期 |
2017.03.21 |
申请号 |
US201514887248 |
申请日期 |
2015.10.19 |
申请人 |
Oyster Point Pharma, Inc. |
发明人 |
Ackermann, Jr. Douglas Michael;Loudin James;Mandell Kenneth J. |
分类号 |
A61K9/00;A61K31/439;A61K31/4439;A61K31/4427;A61K31/4985;A61K45/06;A61K31/4995 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating dry eye, comprising the local administration of a therapeutically effective amount of a nicotinic acetylcholine receptor agonist into the nasal cavity of an individual in need thereof, wherein the agonist selectively binds to the peripheral nicotinic acetylcholine receptor, is administered in a non-systemically bioavailable dose between 5 micrograms and 50 micrograms per dose, and does not cross the blood-brain barrier in a pharmacologically relevant concentration; and wherein the nicotinic acetylcholine receptor agonist is varenicline. |
地址 |
San Francisco CA US |